A detailed history of Acg Wealth transactions in Eli Lilly & CO stock. As of the latest transaction made, Acg Wealth holds 2,782 shares of LLY stock, worth $2.21 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
2,782
Previous 2,781 0.04%
Holding current value
$2.21 Million
Previous $902,000 0.22%
% of portfolio
0.21%
Previous 0.18%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

BUY
$296.48 - $337.87 $296 - $337
1 Added 0.04%
2,782 $900,000
Q2 2022

Jul 13, 2022

SELL
$278.73 - $327.27 $16,166 - $18,981
-58 Reduced 2.04%
2,781 $902,000
Q1 2022

Apr 07, 2022

SELL
$234.69 - $291.66 $57,499 - $71,456
-245 Reduced 7.94%
2,839 $813,000
Q4 2021

Jan 18, 2022

SELL
$224.85 - $279.04 $22,035 - $27,345
-98 Reduced 3.08%
3,084 $852,000
Q3 2021

Nov 01, 2021

SELL
$221.6 - $272.71 $6,648 - $8,181
-30 Reduced 0.93%
3,182 $735,000
Q2 2021

Aug 06, 2021

SELL
$180.55 - $233.54 $75,108 - $97,152
-416 Reduced 11.47%
3,212 $737,000
Q1 2021

May 03, 2021

SELL
$164.32 - $212.72 $254,696 - $329,716
-1,550 Reduced 29.93%
3,628 $678,000
Q4 2020

Feb 02, 2021

SELL
$130.46 - $172.63 $24,004 - $31,763
-184 Reduced 3.43%
5,178 $874,000
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $59,365 - $68,666
406 Added 8.19%
5,362 $794,000
Q2 2020

Oct 07, 2020

BUY
$136.42 - $164.18 $12,277 - $14,776
90 Added 1.85%
4,956 $814,000
Q1 2020

Oct 07, 2020

SELL
$119.05 - $147.35 $126,907 - $157,075
-1,066 Reduced 17.97%
4,866 $675,000
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $42,768 - $52,972
-400 Reduced 6.32%
5,932 $780,000
Q3 2019

Oct 30, 2019

SELL
$106.79 - $116.16 $12,494 - $13,590
-117 Reduced 1.81%
6,332 $708,000
Q2 2019

Aug 06, 2019

BUY
$110.79 - $129.32 $9,306 - $10,862
84 Added 1.32%
6,449 $715,000
Q1 2019

Apr 25, 2019

SELL
$111.31 - $131.02 $21,705 - $25,548
-195 Reduced 2.97%
6,365 $826,000
Q4 2018

Jan 14, 2019

SELL
$105.9 - $118.64 $9,319 - $10,440
-88 Reduced 1.32%
6,560 $759,000
Q3 2018

Oct 09, 2018

BUY
$85.86 - $107.31 $1,202 - $1,502
14 Added 0.21%
6,648 $713,000
Q2 2018

Jul 26, 2018

SELL
$75.7 - $86.88 $4,239 - $4,865
-56 Reduced 0.84%
6,634 $566,000
Q1 2018

Apr 10, 2018

BUY
$74.21 - $87.6 $2,894 - $3,416
39 Added 0.59%
6,690 $518,000
Q4 2017

Feb 08, 2018

SELL
$81.94 - $87.89 $3,523 - $3,779
-43 Reduced 0.64%
6,651 $562,000
Q3 2017

Nov 07, 2017

SELL
$77.07 - $85.54 $17,803 - $19,759
-231 Reduced 3.34%
6,694 $573,000
Q2 2017

Aug 14, 2017

BUY
N/A
6,925
6,925 $571,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Acg Wealth Portfolio

Follow Acg Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acg Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Acg Wealth with notifications on news.